Lacosamide Oral Solution
NDC 82983-427, Lacosamide, solution, from Ajenat Pharmaceuticals LLC.
- Product NDC
- 82983-427
- Status
- Listed
- Labeler
- Ajenat Pharmaceuticals LLC
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219699
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/82983-427 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82983-427-31 | 82983042731 | 200 mL in 1 BOTTLE, PLASTIC (82983-427-31) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cb29da34-89aa-405a-8fbc-2308bda37187NADAC price for package 82983042731
GET /v1/drugs/nadac/82983042731
Use it
Look up 82983-427 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82983-427 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82983-427. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.